Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 3, 1997, Pages 681-686

  Crane, Christopher H ^a   Rich, Tyvin A ^a   Read, Paul W ^a   Sanfilippo, Nicholas J ^a   Gillenwater, Jay Y ^a   Kelly, Maria D ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Prostate specific antigen; Prostatectomy; Prostatic neoplasms; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FINGER; HUMAN; HUMAN TISSUE; MALE; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; RECTUM; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0030920405     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00361-1     Document Type: Article

References (26)

1. Anscher, M. S.; Prosnitz, L. P. Multivariate analysis of factors predicting local relapse after radical prostatectomy: Possible indications for postoperative therapy. Int. J. Radiat. Oncol. Biol. Phys. 21:941-947; 1991.
2. Anscher, M. S.; Prosnitz, L. P. Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement, and/or penetration through the capsule. J. Urol. 138:1407-1412; 1987.
3. Buskirk, S. J.; Schild, S. E.; Durr, E. D.; Robinow, J. S.; Bock, F. F.; Wolfe, J. T.; Tomera, K. M.; Ferrigni, R. G. Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, NO prostate cancer. Mayo Clin. Proc. 71:242-248; 1996.
4. Formenti, S. C.; Lieskovsky, G.; Simoneau, A. R.; Skinner, D.; Groshen, S.; Chen, S.; Petrovich, Z. Impact of moderate dose of postoperative radiation on urinary continence and potency in patients with prostate cancer treated with nerve sparing prostatectomy. J. Urol. 155:616-619; 1996.
5. Gerber, G. S.; Thisted, R. A.; Scardino, P. T.; Frohmuller, H. G.; Schroeder, F. H.; Paulson, D. F.; Middleton, A. W.; Schellhammer, P. F.; Ohori, M.; Chodak, G. W. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA 276:615-619; 1996.
6. Gibbons, R. P.; Cole, B. S.; Richardson, G.; Correa, R. J.; Brannen, G. E.; Mason, J. T. Adjuvant radiotherapy following radical prostatectomy: results and complications. J. Urol. 135: 65-68; 1986.
7. Gong, M.; Ferrari, M.; Stamey, T. Combined androgen deprivation and radiation therapy for treatment of residual prostate cancer following radical prostatectomy. J. Urol. 155:645A; 1996.
8. Jacobson, G. M.; Smith, J. A.; Stewart, J. R. Postoperative irradiation for pathologic stage C prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 13:1021-1024; 1987.
9. Jewett, H. J.; Eggleston, J. C.; Yawn, D. H. Radical prostatectomy in the management of carcinoma of the prostate: Probable cause of some therapeutic failures. J. Urol. 107: 1034-1040; 1972.
10. Kaplan, I. D.; Bagshaw, M. A. Serum prostate-specific antigen after post prostatectomy radiotherapy. Urology 39:401-406; 1992.
11. Keish, M. E.; Perez, C. A.; Grigsby, P. W.; Bauer, W. C.; Catalonia, W. Preliminary report on 10 patients treated with radiotherapy after radical prostatectomy for isolated elevations of serum PSA levels. Int. J. Radiat. Oncol. Biol. Phys. 19: 1503-1506; 1990.
12. Lange, P. H.; Lighter, D. J.; Medini, E.; Reddy, P. K.; Vessella, R. L. The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J. Urol. 144:927-932; 1990.
13. Link, P.; Freiha, F. S.; Stamey, T. A. Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J. Urol. 145:532-534; 1991.
14. McCarthy, J. F.; Catalona, W. J.; Hudson, M. A. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: Early verses delayed treatment. J. Urol. 151:1575-1578; 1994.
15. Meier, R.; Mark, R.; St. Royal, L.; Tran, L.; Colburn, G.; Parker, R. Postoperative radiation therapy after radical prostatectomy for prostate carcinoma. Cancer 70:1960-1966; 1992.
16. Morris, M. M.; Dallow, K. C.; Zeitman, A. L.; Althausen, A. F.; Heney, N. M.; McGovern, F. J.; Shipley, W. U. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:144; 1995.
17. Pilepich, M. V.; Krall, J. M.; Al-Sarraf, M.; Madhu, J. J.; Doggett, R. L. S.; Sause, W. T.; Lawton, C. A.; Abrams, R. A.; Rotman, M.; Rubin, P.; Shipley, W. U.; Grignon, D.; Caplan, R.; Cox, J. D. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45:616-623; 1995.
18. Schild, S. E.; Wong, W. W.; Grado, G. L.; Buskirk, S. J.; Robinow, J. S.; Frick, L. M.; Ferrigni, R. G. Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin. Proc. 69:613-619; 1994.
19. Schild, S. E.; Wong, W. W.; Grado, G. L.; Halyard, M. Y.; Novicki, D. E.; Swanson, S. K.; Larson, T. R.; Ferrigni, R. G. The results of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 34:535-541; 1996.
20. Shevlin, B. E.; Mittal, B. B.; Brand, W. N.; Shetty, R. M. The role of adjuvant irradiation following primary prostatectomy, based on histopathologic extent of tumor. Int. J. Radiat. Oncol. Biol. Phys. 16:1425-1430; 1989.
21. Takayama, T. K.; Lange, P. H. Radiation therapy for local recurrence of prostate cancer after radical prostatectomy. Urol. Clin. North Am. 21:687-700; 1994.
22. Wu, J. J.; King, S. C.; Montana, G. S.; McKinstry, C. A.; Ancher, M. S. The efficacy of postprostatectomy radiotherapy in patients with an elevation of serum prostate-specific antigen. Int. J. Radiat. Oncol. Biol. Phys. 32:317-323; 1995.
23. Yamada, A. H.; Lieskovsky, G.; Petrovich, Z.; Chen, S.; Groshen, S.; Skinner, D. G. Results of radical prostatectomy and adjuvant therapy in the management of locally advanced, clinical stage C, prostate cancer. Am. J. Clin. Oncol. 17:277-285; 1994.
24. Zeitman, A. L. When should radiation therapy follow radical prostatectomy in the management of prostate cancer? Mayo Clin. Proc. 69:700-701; 1994.
25. Zietman, A. L.; Coen, J. J.; Shipley, W. U.; Althausen, A. F. Adjuvant irradiation after radical prostatectomy for adenocarcinoma of the prostate: Analysis of freedom from PSA failure. Urology 42:292-299; 1993.
26. Zietman, A. L.; Shipley, W. U.; Willett, C. G. Residual disease after radical surgery or radiation therapy for prostate cancer. Cancer 71:959-969; 1993.